CareFusion — Q1 FY2011 Earnings Presentation
13 slides from CareFusion's earnings presentation, Nov 2, 2010
Slide 1: Q1 Fiscal 2011 Investor/Analyst Call
Exhibit 99.2 Q1 Fiscal 2011 Investor/Analyst Call November 2, 2010 © 2010 CareFusion Corporation or one of its subsidiaries. All rights reserved.
Slide 2: Forward-Looking Statements and GAAP Reconciliation
Forward-Looking Statements and GAAP Reconciliation “Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: This presentation contains forward-looking statements addressing expectations, prospects, estimates and other matters that are dependent upon future events or develo
Slide 3: Today's Speakers
Today’s Speakers • Dave Schlotterbeck, Chairman and Chief Executive Officer • Ed Borkowski, Chief Financial Officer © 2010 CareFusion Corporation or one of its subsidiaries. All rights reserved. 3
Slide 4: Q1 Fiscal 2011 Results
Q1 Fiscal 2011 Results © 2010 CareFusion Corporation or one of its subsidiaries. All rights reserved.
Slide 5: Q1 Fiscal 2011 Year-Over-Year Quarterly Review
Q1 Fiscal 2011 Year-Over-Year Quarterly Review GAAP Adjusted 1 1 $M % Change $M % Change Revenue $908 (2)% $908 (2)% 2 Operating Expenses $358 7% $318 -- Operating Income 2 $82 (30)% $122 (9)% Income From Continuing $38 (31)% $67 (23)% Operations 3 Diluted EPS From Continuing $0.17 (32)% $0.30 (23)%
Slide 6: Q1 Fiscal 2011 Year-Over-Year Quarterly Segment Review
Q1 Fiscal 2011 Year-Over-Year Quarterly Segment Review GAAP Adjusted Critical Care Technologies (CCT) $M % Change 1 $M % Change 1 Revenues $617 -- $617 -- 2 Segment Profit $71 (30)% $100 (11)% Medical Technologies and Services $M % Change 1 $M % Change 1 (MTS) Revenues $291 (5)% $291 (5)% Segment Pr
Slide 7: Fiscal 2011 Guidance
Fiscal 2011 Guidance © 2010 CareFusion Corporation or one of its subsidiaries. All rights reserved.
Slide 8: Fiscal 2011 Financial Guidance
Fiscal 2011 Financial Guidance 1 Nov. 2, 2010 $ in millions FY11 Outlook Total Revenue (percent growth over FY10) Mid single digits 2 Adjusted Operating Expenses 33% of total revenue Gross Margin ~48% 2 Adjusted Operating Margin ~15% 3 Adjusted Effective Tax Rate 30 - 32% 3 Adjusted Diluted EPS $1.5
Slide 9: Fiscal 2011 Assumptions
Fiscal 2011 Assumptions • Adjusted diluted EPS weighted ~60% to 2H fiscal 2011 • Over 50% of revenue expected in 2H fiscal 2011 • Hospital capital spending grows low to mid single digits; customers continue prioritizing spending • Restructuring provides $85 million to $95 million in pre-tax cost sav
Slide 10: Fiscal 2011 CCT Segment-related Assumptions vs. Fiscal 2010 Results
Fiscal 2011 CCT Segment-related Assumptions vs. Fiscal 2010 Results • Segment revenue grows on a percentage basis by mid single digits Infusion: Revenues grow on a percentage basis in the high teens due to Medegen acquisition and from incremental market share gains in 2HFY11 following FDA requiremen
Slide 11: Fiscal 2011 MTS Segment-related Assumptions vs. Fiscal 2010 Results
Fiscal 2011 MTS Segment-related Assumptions vs. Fiscal 2010 Results • Segment revenue grows on a percentage basis by mid single digits ChloraPrep ® business grows double digits based on successful execution of growth strategy both domestically and internationally Medical Specialties business continu
Slide 12: Q&A
Q&A © 2010 CareFusion Corporation or one of its subsidiaries. All rights reserved.
Slide 13: Q1 Fiscal 2011 Non-GAAP Reconciliations
Q1 Fiscal 2011 Non-GAAP Reconciliations Q1 FY11 Nonrecurring Q1 FY11 $ in millions 1 GAAP Items Adjusted Operating Expenses $358 $(40) $318 Operating Income $82 $40 $122 Income From Continuing Operations $38 $29 $67 Diluted EPS From Continuing 2 $0.17 $0.13 $0.30 Operations Critical Care Technologie